Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 19 | 1.740 |
Why?
|
| Surgical Mesh | 11 | 2014 | 24 | 1.570 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 31 | 1.490 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 17 | 1.210 |
Why?
|
| Postoperative Complications | 20 | 2018 | 996 | 1.190 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 98 | 1.010 |
Why?
|
| Laparoscopy | 13 | 2016 | 171 | 0.960 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 206 | 0.950 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 49 | 0.870 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 32 | 0.720 |
Why?
|
| General Surgery | 4 | 2015 | 58 | 0.610 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 34 | 0.560 |
Why?
|
| Middle Aged | 42 | 2018 | 10235 | 0.550 |
Why?
|
| Gastroplasty | 1 | 2016 | 22 | 0.540 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 21 | 0.520 |
Why?
|
| Gastric Bypass | 1 | 2016 | 66 | 0.500 |
Why?
|
| Aged | 31 | 2018 | 10077 | 0.500 |
Why?
|
| Carcinoma | 3 | 2016 | 64 | 0.500 |
Why?
|
| Male | 45 | 2020 | 16488 | 0.490 |
Why?
|
| Treatment Outcome | 22 | 2018 | 3808 | 0.460 |
Why?
|
| Educational Measurement | 3 | 2015 | 61 | 0.450 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 23 | 0.440 |
Why?
|
| Humans | 60 | 2020 | 31059 | 0.440 |
Why?
|
| Recurrence | 10 | 2017 | 375 | 0.430 |
Why?
|
| Adult | 30 | 2018 | 8945 | 0.430 |
Why?
|
| Quality Improvement | 4 | 2014 | 165 | 0.420 |
Why?
|
| Female | 42 | 2018 | 17005 | 0.410 |
Why?
|
| Hepatectomy | 6 | 2015 | 58 | 0.410 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 74 | 0.410 |
Why?
|
| Retrospective Studies | 25 | 2018 | 3664 | 0.400 |
Why?
|
| Esophagectomy | 5 | 2002 | 24 | 0.390 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 121 | 0.380 |
Why?
|
| Colectomy | 3 | 2016 | 23 | 0.380 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 5 | 0.370 |
Why?
|
| Curriculum | 2 | 2003 | 173 | 0.360 |
Why?
|
| Pancreatic Neoplasms | 5 | 2013 | 155 | 0.340 |
Why?
|
| Students, Medical | 2 | 2013 | 49 | 0.290 |
Why?
|
| Aged, 80 and over | 13 | 2017 | 5196 | 0.290 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 77 | 0.280 |
Why?
|
| Risk Factors | 9 | 2018 | 2587 | 0.270 |
Why?
|
| Survival Rate | 9 | 2015 | 407 | 0.270 |
Why?
|
| Prospective Studies | 9 | 2014 | 1897 | 0.250 |
Why?
|
| Smoking | 2 | 2016 | 197 | 0.250 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 11 | 0.240 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.220 |
Why?
|
| Gastrectomy | 3 | 2015 | 34 | 0.210 |
Why?
|
| Prognosis | 6 | 2017 | 924 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1936 | 0.210 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 90 | 0.210 |
Why?
|
| Cholangiography | 4 | 2015 | 11 | 0.200 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 35 | 0.200 |
Why?
|
| Ultrasonography | 4 | 2020 | 271 | 0.200 |
Why?
|
| Laparotomy | 3 | 2020 | 29 | 0.190 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.190 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 2 | 0.180 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 8 | 0.180 |
Why?
|
| Lymphokines | 1 | 2000 | 14 | 0.180 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 9 | 0.180 |
Why?
|
| United States | 9 | 2016 | 2376 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 69 | 0.180 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 43 | 0.180 |
Why?
|
| Peritoneum | 2 | 2003 | 18 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 64 | 0.170 |
Why?
|
| Adolescent | 6 | 2007 | 2400 | 0.170 |
Why?
|
| Suture Techniques | 3 | 2007 | 145 | 0.160 |
Why?
|
| Pneumonia | 2 | 2016 | 74 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 192 | 0.160 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 4 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2018 | 14 | 0.160 |
Why?
|
| Cholelithiasis | 1 | 1998 | 9 | 0.160 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 12 | 0.160 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 103 | 0.160 |
Why?
|
| Cholecystectomy | 3 | 2013 | 17 | 0.160 |
Why?
|
| Gallstones | 1 | 1998 | 9 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 216 | 0.160 |
Why?
|
| Lipoma | 1 | 2017 | 7 | 0.150 |
Why?
|
| Myoepithelioma | 1 | 2017 | 4 | 0.150 |
Why?
|
| Survival Analysis | 6 | 2015 | 322 | 0.150 |
Why?
|
| Liver | 2 | 1997 | 184 | 0.150 |
Why?
|
| Databases, Factual | 5 | 2016 | 353 | 0.140 |
Why?
|
| Internship and Residency | 3 | 2015 | 227 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2003 | 326 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 4 | 0.140 |
Why?
|
| Trachea | 1 | 1997 | 48 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 59 | 0.140 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.140 |
Why?
|
| Portal Vein | 1 | 1996 | 42 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 172 | 0.130 |
Why?
|
| Thrombosis | 1 | 1996 | 64 | 0.130 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 7 | 0.130 |
Why?
|
| Fundoplication | 2 | 2013 | 20 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 61 | 0.130 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 10 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 49 | 0.130 |
Why?
|
| Organs at Risk | 1 | 2015 | 15 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2015 | 33 | 0.130 |
Why?
|
| Liver Regeneration | 1 | 1995 | 23 | 0.130 |
Why?
|
| Radiation Oncology | 1 | 2015 | 17 | 0.130 |
Why?
|
| Hospital Costs | 1 | 1996 | 69 | 0.120 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 404 | 0.120 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 5 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 453 | 0.120 |
Why?
|
| Logistic Models | 4 | 2016 | 410 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 15 | 0.120 |
Why?
|
| Esophagus | 2 | 2012 | 73 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 12 | 0.120 |
Why?
|
| Clinical Competence | 3 | 2013 | 241 | 0.120 |
Why?
|
| Safety | 2 | 2007 | 50 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 71 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 31 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 46 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 135 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 344 | 0.120 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 34 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.110 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 334 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 28 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 9 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 32 | 0.110 |
Why?
|
| Length of Stay | 5 | 2014 | 339 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1134 | 0.110 |
Why?
|
| Operative Time | 4 | 2014 | 85 | 0.110 |
Why?
|
| Stents | 1 | 1993 | 86 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2013 | 6 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 39 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 344 | 0.110 |
Why?
|
| Sarcoma | 1 | 2015 | 149 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 88 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 153 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 310 | 0.100 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 35 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 181 | 0.100 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 16 | 0.100 |
Why?
|
| Time Factors | 4 | 2014 | 1679 | 0.090 |
Why?
|
| Morbidity | 3 | 2014 | 65 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 27 | 0.090 |
Why?
|
| Reoperation | 5 | 2016 | 952 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2013 | 136 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 409 | 0.080 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 2 | 0.080 |
Why?
|
| Polyurethanes | 1 | 2007 | 9 | 0.080 |
Why?
|
| Omentum | 1 | 2007 | 8 | 0.080 |
Why?
|
| Chicago | 2 | 2001 | 939 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 143 | 0.070 |
Why?
|
| Child | 3 | 2001 | 1428 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 872 | 0.060 |
Why?
|
| Sutures | 2 | 2003 | 46 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 41 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 586 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 416 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 818 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1506 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 507 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 306 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 52 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 208 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 97 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 99 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 37 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 34 | 0.050 |
Why?
|
| Bile | 1 | 2020 | 6 | 0.050 |
Why?
|
| Intraoperative Care | 2 | 1998 | 46 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 13 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 15 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 715 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 12 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1210 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 81 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 104 | 0.040 |
Why?
|
| Infant | 1 | 2001 | 575 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 11 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 689 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 3 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 8 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 26 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 230 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 246 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 636 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 386 | 0.040 |
Why?
|
| Groin | 1 | 2017 | 4 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 32 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2017 | 19 | 0.040 |
Why?
|
| Pilot Projects | 2 | 1997 | 427 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 67 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 87 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 35 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 105 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.040 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.040 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.040 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 2 | 0.040 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 11 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1997 | 26 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 555 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 23 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 430 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 34 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 51 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 2 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 20 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 24 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 149 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 115 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 113 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 147 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 118 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 147 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 70 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 112 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 12 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 508 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 7 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 41 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 695 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 155 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 467 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 288 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 150 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 6 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 266 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 65 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 174 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 4 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 17 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 870 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 523 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 91 | 0.030 |
Why?
|
| Intraoperative Period | 3 | 1997 | 34 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 782 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 661 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 562 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 697 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 26 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 28 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 67 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 4713 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 507 | 0.020 |
Why?
|
| Medical Records | 1 | 2002 | 34 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2002 | 25 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 534 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 11 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 25 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 76 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 119 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 95 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 244 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 12 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 337 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 11 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 109 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 75 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 1321 | 0.010 |
Why?
|